M&T Bank’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,634
Closed -$189K 1559
2025
Q1
$189K Sell
10,634
-1,750
-14% -$31.1K ﹤0.01% 1426
2024
Q4
$369K Sell
12,384
-457
-4% -$13.6K ﹤0.01% 1295
2024
Q3
$201K Sell
12,841
-3,178
-20% -$49.7K ﹤0.01% 1523
2024
Q2
$275K Buy
16,019
+913
+6% +$15.6K ﹤0.01% 1351
2024
Q1
$236K Buy
+15,106
New +$236K ﹤0.01% 1430
2023
Q3
Sell
-4,979
Closed -$206K 1583
2023
Q2
$206K Buy
4,979
+22
+0.4% +$911 ﹤0.01% 1462
2023
Q1
$298K Buy
4,957
+1,058
+27% +$63.5K ﹤0.01% 1305
2022
Q4
$286K Sell
3,899
-876
-18% -$64.3K ﹤0.01% 1323
2022
Q3
$362K Sell
4,775
-301
-6% -$22.8K ﹤0.01% 1208
2022
Q2
$347K Sell
5,076
-193
-4% -$13.2K ﹤0.01% 1126
2022
Q1
$435K Buy
5,269
+2,292
+77% +$189K ﹤0.01% 1051
2021
Q4
$224K Buy
2,977
+211
+8% +$15.9K ﹤0.01% 1391
2021
Q3
$322K Sell
2,766
-379
-12% -$44.1K ﹤0.01% 1199
2021
Q2
$697K Buy
3,145
+238
+8% +$52.7K ﹤0.01% 881
2021
Q1
$383K Sell
2,907
-3,117
-52% -$411K ﹤0.01% 1116
2020
Q4
$1.04M Sell
6,024
-126
-2% -$21.8K ﹤0.01% 760
2020
Q3
$685K Buy
6,150
+2,647
+76% +$295K ﹤0.01% 842
2020
Q2
$208K Sell
3,503
-5
-0.1% -$297 ﹤0.01% 1363
2020
Q1
$236K Buy
3,508
+163
+5% +$11K ﹤0.01% 1258
2019
Q4
$282K Sell
3,345
-229
-6% -$19.3K ﹤0.01% 1115
2019
Q3
$267K Sell
3,574
-639
-15% -$47.7K ﹤0.01% 1263
2019
Q2
$266K Buy
4,213
+13
+0.3% +$821 ﹤0.01% 1289
2019
Q1
$202K Buy
+4,200
New +$202K ﹤0.01% 1414